AMAG Pharma (AMAG) Tops Q1 EPS by 29c; Boosts FY15 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
Go back to AMAG Pharma (AMAG) Tops Q1 EPS by 29c; Boosts FY15 Revenue Outlook
May 5, 2015 7:00 AM EDT
First Quarter 2015 net product sales of $77.4 million and adjusted EBITDA of $47.4 million
Company increases top and bottom line 2015 financial guidance
Conference call scheduled for 8:00 a.m. ET today
WALTHAM, Mass., May 5, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the first quarter of 2015. Total revenues for the first quarter of 2015 increased to $89.5 million, compared with $20.8 million in the first quarter of 2014. This increase was primarily due to the addition... More
May 5, 2015 7:00 AM EDT
First Quarter 2015 net product sales of $77.4 million and adjusted EBITDA of $47.4 million
Company increases top and bottom line 2015 financial guidance
Conference call scheduled for 8:00 a.m. ET today
WALTHAM, Mass., May 5, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG), a specialty pharmaceutical company, today reported unaudited consolidated financial results for the first quarter of 2015. Total revenues for the first quarter of 2015 increased to $89.5 million, compared with $20.8 million in the first quarter of 2014. This increase was primarily due to the addition... More
